Novacyt SA NVYTF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.48
- Day Range
- $0.57–0.57
- 52-Week Range
- $0.48–0.57
- Bid/Ask
- $0.00 / $4,000.58
- Shares Outstanding
- 72.52M
- Market Cap
- $40.29M
- Volume/Avg
- 830 / 408
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.39
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, Yourgene Health and Corporate. Majority of the revenue is generated from Yourgene Health segment. Geographically, the company operates in United Kingdom, France, Europe, America, Asia-Pacific, Middle East and Africa generating majority from Asia- pacific region.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 216
- Website
- https://www.novacyt.com
Valuation
|
Metric
|
NVYTF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.67 |
Price/Sales | 1.39 |
Price/Cash Flow | — |
Price/Earnings
NVYTF
Financial Strength
|
Metric
|
NVYTF
|
|---|---|
Quick Ratio | 2.19 |
Current Ratio | 3.14 |
Interest Coverage | −44.85 |
Quick Ratio
NVYTF
Profitability
|
Metric
|
NVYTF
|
|---|---|
Return on Assets (Normalized) | −15.00% |
Return on Equity (Normalized) | −25.49% |
Return on Invested Capital (Normalized) | −17.17% |
Return on Assets
NVYTF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|g?@mCkK | LOCK|yvf& | $179B | |||
| Medtronic PLC
MDT
| LOCK|lMK$%%g | LOCK|R#g! | $122B | |||
| Stryker Corp
SYK
| LOCK|j@<Pd^y | LOCK|x&& | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|$j<Zbt | LOCK|wcR&$ | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|nT#tC!> | LOCK|RzpW | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|@VGRnJ | LOCK|%%d | $32B | |||
| DexCom Inc
DXCM
| LOCK|@%qq!&j | LOCK|vPQq | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|c#y | LOCK|?K | $26B | |||
| Steris PLC
STE
| LOCK|>$p%!^ | LOCK|BX!tn | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|TX&Md<&$ | LOCK|r! | $19B |
United States